首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1392090

联合化疗市场：依药物类型、製剂环境、给药途径、病患类型、癌症类型、配销通路、製剂方法、包装类型、法规遵循、地区

Compounding Chemotherapy Market, By Drug Type, By Compounding Setting, By Route of Administration, By Patient Type, By Cancer Type, By Distribution Channel, By Compounding Method, By Packaging Type, By Regulatory Compliance, By Geography

出版日期: 2023年11月16日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年全球联合化疗市场规模为52.9亿美元，预估2023年至2030年复合年增长率为4.9%，2030年达74.1亿美元。

报告范围		报告详情
基准年	2022年	2023年市场规模	52.9亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	4.90%	2030年市场规模预测	74.1亿美元

图 1. 2023 年按地区分類的联合化疗全球市场占有率(%)

合併化疗是指将药物成分客製化为适合个别患者需求的药物。这主要是由于全球癌症发生率不断上升以及对专门药物製剂的需求。随着癌症治疗变得更加个体化，化合物在为患者提供适合其特定疾病、状况和易感性的正确配方方面发挥着重要作用。日益增长的老年人口（更容易患癌症）、对精准医疗和标靶治疗的日益关注以及成药的稀缺是推动全球普及联合化疗服务的一些关键因素。

市场动态：

癌症、骨髓疾病和免疫系统问题等疾病的盛行率不断上升也可能推动预测期内全球联合化疗市场的成长。处方药成本的上涨和支付政策的变化预计将在预测期内再次促进全球联合化疗市场的成长。增加产品对消费者健康的益处为全球联合化疗市场创造了新的机会。医院和医疗产业对联合化疗和药物的认识不断提高也推动了市场扩张。

根据世界卫生组织 (WHO) 统计，自 2000 年以来，受癌症影响的人数几乎增加了一倍，预计未来 20 年将增加 70% 以上。对个体化治疗选择和基于价值的护理模式的认识不断提高，促使肿瘤科医生实施药房服务。此外，成药的缺乏，特别是针对儿童癌症的非处方药的缺乏，为该市场的参与企业提供了成长机会。然而，污染风险、製备复杂配方的技术挑战以及各国法规环境不一致也可能阻碍市场扩张。 3D 列印在药房配药中的日益增长的应用可能会在未来几年为改进药物传输和个体化给药设计开闢新途径。

本研究的主要特点

本报告详细分析了全球联合化疗市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球联合化疗市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
全球联合化疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球联合化疗市场的各种策略矩阵，将有助于相关人员做出决策。

Braun Melsungen AG
Fagron NV
PharMEDium Services, LLC（AmerisourceBergen Corporation）
Baxter International Inc.
Fresenius Kabi AG
Advanced Pharma, Inc.
McGuff Compounding Pharmacy Services, Inc.
Central Admixture Pharmacy Services, Inc.（CAPS）
Institutional Pharmacy Solutions, LLC
Wedgewood Pharmacy
Medisca Inc.
Dougherty's Holdings, Inc.
PharMEDium Services, LLC（AmerisourceBergen Corporation）
BioScrip, Inc.

第16章章节

调查方法
关于出版商

简介目录

Product Code: CMI5892

The Global Compounding Chemotherapy Market size was valued at US$ 5.29 Bn in 2023 and is projected to reach US$ 7.41 Bn by 2030, growing at a CAGR of 4.9% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.29 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.90%	2030 Value Projection:	US$ 7.41 Bn

Figure 1. Global Compounding Chemotherapy Market Share (%), by Region, 2023

Compounding chemotherapies refer to the customization of pharmaceutical ingredients into medication tailored to individual patient needs. This has been largely driven by the rise in cancer prevalence worldwide and the need for specialized drug formulations. As cancer treatments become more personalized, compounding plays a crucial role in providing patients with formulations suited to their specific disease, condition, or sensitivity. Growing geriatric population prone to developing cancers, increasing emphasis on precision medicine and targeted therapies, and shortages of commercially available drugs are some of the key factors fueling the adoption of compounding chemotherapy services globally.

Market Dynamics:

The increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems will continue to fuel the growth of the global compounding chemotherapy market over the forecast period. Increasing costs for prescription drugs and changing payment policies are again expected to augment global compounding chemotherapy market growth over the forecast period. Rising consumer health benefits from the products will create new opportunities for the global compounding chemotherapy market. Hospitals and the healthcare industry are becoming more aware of compounded chemotherapy treatments or medicines, which is also assisting in the market's expansion.

According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by over 70% in the next two decades. Increased awareness about personalized treatment options and value-based healthcare models is encouraging oncology practitioners to adopt compounding services. The shortage of commercially manufactured drugs, especially for pediatric cancer, also presents growth opportunities for players in this market. However, risks of contamination, technical challenges in preparing complex formulations, and an inconsistent regulatory environment across countries could hinder the market expansion to some extent. The growing application of 3D printing in pharmacy compounding is likely to open up new avenues, allowing for improved drug delivery and personalized dosage designs in the coming years.

Key features of the study:

This report provides in-depth analysis of the global compounding chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global compounding chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include B. Braun Melsungen AG, Fagron NV, PharMEDium Services, LLC (AmerisourceBergen Corporation), Baxter International Inc., Fresenius Kabi AG, Advanced Pharma, Inc., McGuff Compounding Pharmacy Services, Inc., Central Admixture Pharmacy Services, Inc. (CAPS), Institutional Pharmacy Solutions, LLC, Wedgewood Pharmacy, Medisca Inc., Dougherty's Holdings, Inc., PharMEDium Services, LLC (AmerisourceBergen Corporation), BioScrip, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global compounding chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding chemotherapy market

Global Compounding Chemotherapy Market Detailed Segmentation:

By Drug Type:
- Cytotoxic Drugs
- Hormonal Agents
- Immunomodulatory Agents
- Targeted Therapies
- Supportive Care Drugs
By Compounding Setting:
- Hospital Compounding
- Compounding Pharmacies
- Specialty Clinics
- Homecare Settings
By Route of Administration:
- Intravenous (IV)
- Oral
- Subcutaneous (SC)
- Intramuscular (IM)
- Intrathecal (IT)
By Patient Type:
- Adult Patients
- Pediatric Patients
- Geriatric Patients
By Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
- Lymphoma
- Other specific cancer types
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Compounding Method:
- Aseptic Compounding
- Non-aseptic Compounding
By Packaging Type:
- Vials
- Ampoules
- Pre-filled Syringes
- Bottles
By Regulatory Compliance:
- USP Chapter <797> Compliance
- FDA Regulations
- EMA Regulations
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile:
- Braun Melsungen AG
- Fagron NV
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Baxter International Inc.
- Fresenius Kabi AG
- Advanced Pharma, Inc.
- McGuff Compounding Pharmacy Services, Inc.
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Institutional Pharmacy Solutions, LLC
- Wedgewood Pharmacy
- Medisca Inc.
- Dougherty's Holdings, Inc.
- BioScrip, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Compounding Chemotherapy, By Drug Type
- Market Compounding Chemotherapy, By Compounding Setting
- Market Compounding Chemotherapy, By Route of Administration
- Market Compounding Chemotherapy, By Patient Type
- Market Compounding Chemotherapy, By Cancer Type
- Market Compounding Chemotherapy, By Distribution Channel
- Market Compounding Chemotherapy, By Compounding Method
- Market Compounding Chemotherapy, By Packaging Type
- Market Compounding Chemotherapy, By Regulatory Compliance
- Market Compounding Chemotherapy, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing demand for Personalized Medicine
Increasing prevalence of illnesses like cancer
- Restraints
The High cost of compounding chemotherapeutic products
- Opportunities
Rising consumer health benefits from the products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Compounding Chemotherapy Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Compounding Chemotherapy Market , By Drug Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cytotoxic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hormonal Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Immunomodulatory Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Targeted Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Supportive Care Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Compounding Chemotherapy Market , By Compounding Setting, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Compounding Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Compounding Chemotherapy Market , By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Intrathecal (IT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Compounding Chemotherapy Market , By Patient Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pediatric Patients
Geriatric Patients

9. Compounding Chemotherapy Market , By Cancer Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Lung Cancer
Colorectal Cancer
Prostate Cancer
Leukemia
Lymphoma
Other specific cancer types

10. Compounding Chemotherapy Market , By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies

11. Compounding Chemotherapy Market , By Compounding Method, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Aseptic Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Non-aseptic Compounding

12. Compounding Chemotherapy Market , By Packaging Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Ampoules
Pre-filled Syringes
Bottles

13. Compounding Chemotherapy Market , By Regulatory Compliance, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
USP Chapter <797> Compliance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
FDA Regulations
EMA Regulations

14. Compounding Chemotherapy Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
GCC
Israel
Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa

15. Competitive Landscape

Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fagron NV
PharMEDium Services, LLC (AmerisourceBergen Corporation)
Baxter International Inc.
Fresenius Kabi AG
Advanced Pharma, Inc.
McGuff Compounding Pharmacy Services, Inc.
Central Admixture Pharmacy Services, Inc. (CAPS)
Institutional Pharmacy Solutions, LLC
Wedgewood Pharmacy
Medisca Inc.
Dougherty's Holdings, Inc.
PharMEDium Services, LLC (AmerisourceBergen Corporation)
BioScrip, Inc.
Analyst Views

16. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

联合化疗市场：依药物类型、製剂环境、给药途径、病患类型、癌症类型、配销通路、製剂方法、包装类型、法规遵循、地区